Compass Pathways Plc (CMPS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Compass Pathways Plc stock (CMPS) is currently trading at $5.22. Analyst consensus price target for CMPS is $21.92. WallStSmart rates CMPS as Sell.
- CMPS PE ratio analysis and historical PE chart
- CMPS PS ratio (Price-to-Sales) history and trend
- CMPS intrinsic value — DCF, Graham Number, EPV models
- CMPS stock price prediction 2025 2026 2027 2028 2029 2030
- CMPS fair value vs current price
- CMPS insider transactions and insider buying
- Is CMPS undervalued or overvalued?
- Compass Pathways Plc financial analysis — revenue, earnings, cash flow
- CMPS Piotroski F-Score and Altman Z-Score
- CMPS analyst price target and Smart Rating
Compass Pathways
📊 No data available
Try selecting a different time range
Smart Analysis
Compass Pathways Plc (CMPS) · 4 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around return on equity and price/book. Significant fundamental concerns warrant caution or avoidance.
Compass Pathways Plc (CMPS) Key Strengths (1)
52.96% held by institutions, strong professional interest
Supporting Valuation Data
Compass Pathways Plc (CMPS) Areas to Watch (3)
Company is destroying shareholder value
Very expensive at 16.3x book value
Small-cap company with higher risk but more growth potential
Compass Pathways Plc (CMPS) Detailed Analysis Report
Overall Assessment
This company scores 12/100 in our Smart Analysis, earning a F grade. Out of 4 metrics analyzed, 1 register as strengths (avg 8.0/10) while 3 fall into concern territory (avg 2.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own..
The Bear Case
The primary concerns are Return on Equity, Price/Book, Market Cap. Some valuation metrics including Price/Book (16.28) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -205.80%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -205.80% needing improvement to support the investment thesis. Third, top-line growth trajectory.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Price/Book are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CMPS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
Compare CMPS with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Compass Pathways Plc (CMPS) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Compass Pathways Plc operates as a stable business with moderate growth and solid fundamentals. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Free cash flow is -38M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Volatility is elevated with a beta of 1.98, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Compass Pathways Plc.
Bottom Line
Compass Pathways Plc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Compass Pathways Plc(CMPS)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
COMPASS Pathways plc is a mental health care company in the United Kingdom and the United States. The company is headquartered in Cheshire, the United Kingdom.